πŸ›οΈ Verified NIH Record β€’ Updated 2024-11-19

Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center (NCT04920253)

🟒 Recruiting Observational / Diagnostic βš™οΈ Medical Device Protocol Sponsor: Medaxis, LLC

🩺 Plain-English Summary (8th-Grade Level)

Prospective, single-blinded, single-center, parallel group, randomized controlled trial (RCT) to assess rate and frequency of wound healing and associated financial savings, when using Medaxis debritom+ versus standard of care as a choice of debridement method, where both arms follow normal wound care practice in use of advanced wound care treatments.

Who can join: Review the eligibility criteria below.

Location: MCR Health, Inc. β€” Bradenton, Florida

Age range: 18 Years

πŸ§ͺ Interventions in This Study

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (1 Sites)

  • MCR Health, Inc. β€” Bradenton, Florida

πŸ“ž Contact the Study Coordinator

Phone: (646) 369-1570

Email: ssegal-leibovich@namsa.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—